Forman SJ - Search Results

1

Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange.

Wu AM, Tan GJ, Sherman MA, Clarke P, Olafsen T, Forman SJ, Raubitschek AA. Wu AM, et al. Among authors: forman sj. Protein Eng. 2001 Dec;14(12):1025-33. doi: 10.1093/protein/14.12.1025. Protein Eng. 2001. PMID: 11809933

2

CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy.

Jensen M, Tan G, Forman S, Wu AM, Raubitschek A. Jensen M, et al. Biol Blood Marrow Transplant. 1998;4(2):75-83. doi: 10.1053/bbmt.1998.v4.pm9763110. Biol Blood Marrow Transplant. 1998. PMID: 9763110 Free article.

3

Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.

Wong JY, Somlo G, Odom-Maryon T, Williams LE, Liu A, Yamauchi D, Wu AM, Yazaki P, Wilczynski S, Shively JE, Forman S, Doroshow JH, Raubitschek AA. Wong JY, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3224s-3231s. Clin Cancer Res. 1999. PMID: 10541368 Clinical Trial.

4

Human T lymphocyte genetic modification with naked DNA.

Jensen MC, Clarke P, Tan G, Wright C, Chung-Chang W, Clark TN, Zhang F, Slovak ML, Wu AM, Forman SJ, Raubitschek A. Jensen MC, et al. Among authors: forman sj. Mol Ther. 2000 Jan;1(1):49-55. doi: 10.1006/mthe.1999.0012. Mol Ther. 2000. PMID: 10933911 Free article.

5

Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy.

Jensen MC, Cooper LJ, Wu AM, Forman SJ, Raubitschek A. Jensen MC, et al. Among authors: forman sj. Cytotherapy. 2003;5(2):131-8. doi: 10.1080/14653240310001028. Cytotherapy. 2003. PMID: 12745575

6

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.

McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell SR. McLaughlin-Taylor E, et al. Among authors: forman sj. J Med Virol. 1994 May;43(1):103-10. doi: 10.1002/jmv.1890430119. J Med Virol. 1994. PMID: 8083644

7

Ex vivo expansion of transplantable human hematopoietic stem cells: where do we stand in the year 2000?

Shih CC, DiGiusto D, Forman SJ. Shih CC, et al. Among authors: forman sj. J Hematother Stem Cell Res. 2000 Oct;9(5):621-8. doi: 10.1089/15258160050196650. J Hematother Stem Cell Res. 2000. PMID: 11091485 Review.

8

Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein.

Pande H, Campo K, Tanamachi B, Forman SJ, Zaia JA. Pande H, et al. Among authors: forman sj. Scand J Infect Dis Suppl. 1995;99:117-20. Scand J Infect Dis Suppl. 1995. PMID: 8668934

9

Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line.

Snyder DS, Wu Y, Wang JL, Rossi JJ, Swiderski P, Kaplan BE, Forman SJ. Snyder DS, et al. Among authors: forman sj. Blood. 1993 Jul 15;82(2):600-5. Blood. 1993. PMID: 8329715 Free article.

10

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR. Slovak ML, et al. Among authors: forman sj. Blood. 2000 Dec 15;96(13):4075-83. Blood. 2000. PMID: 11110676 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

656 results

Search Page